The Division of Pediatric Hematology-Oncology is located at PCH, which is ranked by U.S. News among the top 20 programs in the nation https://medicine.utah.edu/pediatrics/hematology_oncology/. The program has focused expertise in Oncology, Hematology, Transplantation and Cellular Therapy, Population Sciences, Cancer Control, and Pediatric Cancer Genetics and sees over 220 newly diagnosed children annually. The Department of Pediatrics ranks among the top 15 Pediatric Departments in NIH funding and has a premier Research Enterprise providing infrastructure, faculty mentoring, and grant writing support. The U of U also has a robust biotechnology and venture commercialization program.
HCI is an NCI-designated Comprehensive Cancer Center and a member of the National Comprehensive Cancer Network (NCCN), supporting and fostering a vibrant cancer research enterprise in a collegial environment. HCI has an outstanding history of academic achievement and impact, a collaborative environment, and a commitment to excellence in patient care, research, teaching, and service. Our integrated health system and HCI’s participation in the ORIEN network of leading cancer centers provide opportunities for multidisciplinary collaborations in basic and translational laboratory-based cancer research, epidemiology and cancer biostatistics, as well as population-based studies of childhood, adolescent, and young adult cancers and outcomes. In addition, the U of U Health and HCI are home to superb shared resources, such as the Utah Population Database with more than 16 million records linking genealogies, health records, and vital statistics, as well as the Utah Cancer Registry which is a long-standing and preeminent SEER site. www.huntsmancancer.org; www.cores.utah.edu.
Qualified candidates are expected to hold a Ph.D., M.D. or D.O. degree, and must have focused training in population sciences and/or cancer control related to pediatric cancer. Qualified candidates at the Assistant Professor level should have a track record of innovative research and peer-reviewed publications of impact in the areas of cell therapy, cancer genetics, epigenetics, tumor modeling and/or experimental therapeutics. Qualified candidates who additionally have an extensive track record, and an established history of extramural funding will be considered for appointment at the rank of Associate Professor or Professor. Candidates who desire to participate in patient care, must also be Board Eligible/Board Certified in Pediatric Hematology Oncology.
A cover letter containing a description of professional experience and the names and contact information of three professional references; a curriculum vitae; a three-page research plan; and a description (up to one page) of contributions and plans related to equity, diversity and inclusion must be submitted at the time of application. Interested individuals can apply for the position at:
https://utah.peopleadmin.com/postings/123319. For additional information about the position, please contact Michael Pulsipher M.D. at [email protected].
The University of Utah Health (U of U Health) is a patient focused center distinguished by collaboration, excellence, leadership, and respect. The U of U Health values candidates who are committed to fostering and furthering the culture of compassion, collaboration, innovation, accountability, diversity, integrity, quality, and trust that is integral to our mission. HCI is committed to hiring individuals whose merit and experience promote a diverse, inclusive, anti-racist workforce and culture. Learn more about HCI’s commitments at huntsmancancer.org/edi.
Source: Indeed.com
Click Here To Apply